Ipratropium bromide and albuterol sulfate inhalation solution

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Efficacy and Safety of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution

Combination Therapy in COPD: Enhanced Bronchodilation

Keywords: COPD, combination therapy, bronchodilation

The combination of ipratropium bromide (IB) and albuterol sulfate (ALB) has been shown to provide superior bronchodilation compared to either agent alone in patients with chronic obstructive pulmonary disease (COPD). A study involving 652 patients with moderate to severe COPD demonstrated that the combination therapy significantly improved acute spirometric response and evening peak expiratory flow rate (PEFR) values over an 85-day period without increasing adverse events . This enhanced efficacy was also observed in a 29-day trial where the combination therapy resulted in greater improvements in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) compared to albuterol base alone .

Asthma Management: Improved Pulmonary Function

Keywords: asthma, pulmonary function, FEV1

In patients with moderate-to-severe asthma, the combination of ipratropium bromide and albuterol sulfate has been shown to provide better bronchodilation than albuterol alone. A crossover trial involving 226 patients found that the combination therapy significantly improved peak FEV1 and FEV1 area under the curve (AUC0-6h) compared to albuterol alone, with treatment differences favoring the combination observed at every post-dose timepoint . Another study in an emergency department setting showed that patients receiving the combination therapy had a greater improvement in pulmonary function and a lower rate of hospital admissions compared to those receiving albuterol alone .

Acute Asthma: Rapid Response and Hospitalization Rates

Keywords: acute asthma, emergency department, hospitalization

For acute asthma exacerbations, the combination of ipratropium bromide and albuterol sulfate has been found to be more effective than albuterol alone in improving pulmonary function and reducing hospital admissions. In a study of 180 patients presenting to an emergency department, those treated with the combination therapy showed a significantly greater improvement in peak expiratory flow (PEF) and FEV1, and had a lower rate of hospital admissions compared to those treated with albuterol alone . However, another study with 384 emergency department patients found no significant additive benefit of the combination therapy over albuterol alone in terms of FEV1 improvement or hospitalization rates .

Pharmacoeconomic Benefits in COPD

Keywords: pharmacoeconomics, COPD, cost-effectiveness

The combination of ipratropium bromide and albuterol sulfate not only improves clinical outcomes but also offers pharmacoeconomic benefits. A post hoc evaluation of two studies involving 1,067 COPD patients revealed that the combination therapy resulted in fewer COPD exacerbations, reduced hospital days, and lower use of antibiotics and corticosteroids compared to albuterol alone. Consequently, the total treatment cost was significantly lower for the combination therapy, making it a more cost-effective option .

Conclusion

The combination of ipratropium bromide and albuterol sulfate inhalation solution has been consistently shown to provide superior bronchodilation and improved pulmonary function in both COPD and asthma patients compared to either agent alone. This combination therapy is effective in both chronic management and acute exacerbations, offering significant clinical and pharmacoeconomic benefits without increasing adverse effects.

Sources and full results

Most relevant research papers on this topic

Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.

Combining ipratropium and albuterol inhalation solution provides better bronchodilation than either therapy alone in COPD patients without increasing side effects.

RCTLarge Human TrialHighly Cited

1997·

151citations

·D. Auerbach et al.

Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon Metered-Dose Inhaler and Albuterol Hydrofluoroalkane Metered-Dose Inhaler in a Crossover Trial in Patients with Moderate-to-Severe Asthma

Combivent CFC MDI (CVT) provides better bronchodilation than albuterol alone in patients with moderate-to-severe asthma, with a generally balanced adverse event profile.

RCTRigorous Journal

2011·

0citations

·E. Bleecker et al.

First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.

Ipratropium bromide combined with albuterol significantly improves pulmonary function and reduces hospital admissions in acute asthma patients.

RCTHighly Cited

2000·

165citations

·G. Rodrigo et al.

Ipratropium Bromide/Albuterol Sulfate

I was 73 Kg (161 Lb) at the start and 69.8 Kg (154 Lb) at the end, a loss of 3.2 Kg (7.1 Lb) salbutamol ipratropium bromide drug study ipratropium bromide + albuterol sulfate That was never as true as in politics today ipratropium bromide albuterol sulfate inhalation solution albuterol atrovent nebulizer dose where to buy ipratropium bromide nasal spray (e) You're mistaking populism with demagoguery ipratropium bromide nebuliser dosage ipratropium bromide vs albuterol ipratropium bromide nasal solution 0.06 side effects So I got behind the wheel during a typically sweltering New York summer week, and gave the GT a spin. albuterol and ipratropium bromide solutions albuterol ipratropium nebulizer dose

2013·

0citations

·B. Moller

A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma.

Nebulized ipratropium bromide and albuterol showed no significant additive benefit in treating acute asthma in inner city patients.

RCTLarge Human TrialHighly Cited

1996·

80citations

·Jill P. Karpel et al.

For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.

A combination of ipratropium bromide and albuterol sulfate is more effective at improving pulmonary function than albuterol base alone for COPD patients, with no increased adverse effects.

1999·

60citations

·S. Campbell

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.

Ipratropium combined with albuterol significantly reduces COPD exacerbations and costs, making it a cost-effective treatment option for patients.

RCTLarge Human TrialHighly Cited

1999·

177citations

·M. Friedman et al.

Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

Combination albuterol-ipratropium therapy was once an innovative treatment for COPD, but newer treatments have surpassed its advantages in improving airflow and simplifying therapy.

Systematic Review

2010·

21citations

·J. Gordon et al.

Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma.

Ipratropium/fenoterol combination significantly improves pulmonary function in children with acute asthma compared to ipratropium alone, but fenoterol alone shows no significant improvement.

RCT

1988·

64citations

·Wade T.A. Watson et al.

Effects of inhalation of albuterol sulphate, ipratroprium bromide and frusemide on breathing mechanics and gas exchange in healthy exercising horses.

Pre-exercise inhalation of bronchodilators by healthy horses is unlikely to improve performance capacity due to the normal sympathetic response to exercise.

Non-RCTAnimal Study

2010·

10citations

·W. Bayly et al.

Try another search

space shuttle take off

how fast do space shuttles travel

carbon dioxide gas

moon mission

rocks in space

inside of a cell